skip to main content

ES

Saluting Dr. Mileka Gilbert 

This pediatric rheumatologist is committed to supporting the Arthritis Foundation's efforts to reach all people with arthritis.

Mileka Gilbert, MD, PhD, a pediatric rheumatologist and scientis, is also a committed volunteer with the Arthritis Foundation. She is especially interested in helping to ensure that the rheumatology community expands its reach to serve all people who care, including those who have historically received less than superior care. 
A person smiling for the cameraDescription automatically generated with low confidenceDr. Gilbert grew up in Mississippi and moved with her family to Maryland when she was in middle school. A sports enthusiast, she played basketball in high school and spent time as a student athletic trainer during college, working with physical therapists and trainers to treat and rehabilitate injuries incurred by varsity sports athletes. It was her interest in sports that drew her to a career in medicine.

“I was curious about bones and joints and how your body moves,” she explains. “When I decided to go to medical school, I eventually chose rheumatology, which was the perfect blend of all my intellectual interests.”

Dr. Gilbert earned her MD and PhD in microbiology and immunology at the University of North Carolina at Chapel Hill, and then completed pediatric training at the Virginia Commonwealth University Heath System. In 2015, after finishing her fellowship at the University of Texas Southwestern Medical Center, Dr. Gilbert began practicing pediatric rheumatology with the Medical University of South Carolina (MUSC) in Charleston, S.C.

Today, Dr. Gilbert sees children with arthritis and related pediatric rheumatic diseases, including lupus, scleroderma, dermatomyositis and vasculitis. She is especially interested in advancing lupus research and improving health outcomes through quality improvement initiatives.

Dr. Gilbert says these chronic illnesses usually require long-term treatments with medications. “Together, the family and I decide what is the best medication for the patient’s diagnosis, but also what medication might be most feasible for the patient’s and family’s situation.”

She believes that working with groups in medical centers across the country brings great opportunities for patients to participate in research studies. “These studies help us improve outcomes in patients. What you get from us at MUSC is not just our expertise, but also shared expertise from other rheumatologists. That’s how we’re changing what’s possible for patients.”

A group of people smilingDescription automatically generated with medium confidence

Besides participating in the Arthritis Foundation’s Jingle Bell Run and Walk to Cure Arthritis fundraising events in her area — along with the MUSC team of other physicians and their patients and families, as well as MUSC fellows in rheumatology training — Dr. Gilbert also serves on the Arthritis Foundation’s Community Health Expert Working Group. Here, she contributes to discussions about ways to close gaps faced by people in marginalized communities. The Arthritis Foundation awarded nearly $400,000 in Community Health fellowship grants to help improve health outcomes and address disparities among patients with rheumatic diseases, especially those in underserved communities. 

“I’ve always had an interest in learning about how people of diverse backgrounds and cultures can live and work together,” Dr. Gilbert says. “The more ideas and perspectives you have at the table, the greater opportunity there is to solve these complicated problems in the delivery of care.”

She continues: “One problem we have, particularly in rheumatology, is the lack of diversity within our workforce. I’m happy to be part of the Arthritis Foundation’s efforts to come up with ideas to increase workforce diversity and recruit people from different backgrounds to our field.

“Rheumatology is a growing field but is also changing very rapidly. An important task we have is getting this new information and new medicines out there to those who are most in need, not only by providing access to care but also figuring out which therapies are most appropriate to our patients and their families. The only way to know that is to get people from different backgrounds and experiences together to help think about what that’s like for patients of different cultures.”

As technology continues to grow, so will the understanding of how rheumatic disease processes work, Dr. Gilbert concludes, which will lead to more specific, targeted therapies.

“We must understand our patients and their families by having very open conversations about what they need,” she says. “Most health care actually occurs outside the physician office, so we have to do a better job as providers to understand their home life, work life and school life — and what works best for them in their own self-care.”